	Comorbid
Psoriasis
Quality-of-life
Biologics
Inflammation
	psoriasis patients
patients
cardiovascular disease
inflammatory conditions
psoriasis treatment
cardiovascular events
psoriasis
years
controls
age
disease
mortality
risk
conditions
cells
comorbidities
effective
significantly
factors
common
joint involvement
population
synthetic antimalarial drugs
disease associations
methotrexate
body surface area
relative risk
Conditions such
Common inflammatory pathways
concomitant therapy
triglycerides
twofold increase
drugs
atopic dermatitis
diagnosis
markers
study
higher
lipoprotein
mechanisms
treatment
chronic
infection
SMR
systemic inflammation
prevalence
atherosclerosis
due

